BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2001
View Archived Issues
SPP-301 enters phase I evaluation
Read More
Kucera focuses on prodrug carriers for various diseases
Read More
Company Profile: Prana Biotechnology
Read More
Servier characterizes mixed TP/5-HT2A receptor antagonist at ISTH meeting
Read More
Novel anticoagulant targets surface-bound thrombin, may be preferable to heparin
Read More
Orally active gpIIb/IIIa antagonist shows broad-spectrum antiplatelet effects
Read More
Antithrombin and antithrombotic effects of LB-30057 discussed at ISTH meeting
Read More
ISTH news: antiplatelet/anticoagulant effects of PI-88 characterized
Read More
Ivax boosts immunotoxin program with new agreement
Read More
CS-747 emerges as a useful antiplatelet agent for thrombotic disorders
Read More
Pharmexa begins phase I/II trial of therapeutic vaccine for breast cancer in Denmark
Read More
FDA requests further data on Xolair, delaying approval
Read More
NeoGenesis and Biogen expand small-molecule research alliance
Read More
Committee concludes positive interim safety review of tgAAVCF trial
Read More
Synthetic heparin mimetic exerts potent antithrombotic activity with less hemostatic impairment
Read More
Ad-vIL-10 as a promising strategy for human uveitis
Read More
Aventis transfers selected product rights to Introgen Therapeutics through investment
Read More
WHI-P131 useful for preventing colorectal cancer
Read More
Antithrombotics for both intravenous and oral administration patented by Fournier
Read More
Japanese lab prepares anti-HIV thiamine disulfides with improved water solubility
Read More
Kissei presents new series of D2 antagonists/5-HT4 agonists
Read More
Potent antiarthritic compounds from Dainippon with excellent safety
Read More
Inhibitors of sPLA2 and their use reported by Shionogi team
Read More
Adolor's ADL-8-2698 enters phase III for second indication
Read More
S-Allylmercaptoglutathine useful for atherosclerosis, lipid and weight disorders, cancer, etc.
Read More
SCRAS patents new series of inhibitors of NOS and/or MAO
Read More
Promising phase III trial results reported with Leuprogel three-month depot
Read More
